Compare IMKTA & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMKTA | PRGO |
|---|---|---|
| Founded | 1963 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Food Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 1994 | 2013 |
| Metric | IMKTA | PRGO |
|---|---|---|
| Price | $86.83 | $11.17 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $19.33 |
| AVG Volume (30 Days) | 108.6K | ★ 2.2M |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | 0.74% | ★ 10.28% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,334,032,609.00 | $800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.02 |
| P/E Ratio | $15.91 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $59.09 | $9.23 |
| 52 Week High | $95.62 | $28.44 |
| Indicator | IMKTA | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 46.74 | 49.34 |
| Support Level | $81.40 | $10.40 |
| Resistance Level | $89.76 | $12.36 |
| Average True Range (ATR) | 2.73 | 0.48 |
| MACD | -0.10 | -0.10 |
| Stochastic Oscillator | 40.30 | 31.31 |
Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.